Bepridil

71 interactions 4 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Famotidine Encorafenib Dasatinib Glasdegib Oxaliplatin Injection Ofloxacin

63 Contraindicated 7 Major 1 Moderate

All (71) Contraindicated (63) Major (7) Moderate (1)

Contraindicated

Bepridil Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Bepridil Sertraline Explained An increased risk of QT interval prolongation Details Bepridil Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Bepridil Relugolix Orgovyx Explained An increased risk of QT interval prolongation Details Bepridil Amisulpride Injection Barhemsys An increased risk of QT interval prolongation Details Bepridil Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Bepridil Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Bepridil Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Bepridil Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Bepridil Azithromycin AzaSite An increased risk of QT interval prolongation Details Bepridil Alfuzosin UroXatral An increased risk of QT interval prolongation Details Bepridil Anagrelide Agrylin An increased risk of QT interval prolongation Details Bepridil Bedaquiline Sirturo An increased risk of QT interval prolongation Details Bepridil Chloroquine Aralen® An increased risk of QT interval prolongation Details Bepridil Dasatinib Phyrago An increased risk of QT interval prolongation Details Bepridil Degarelix Injection Firmagon An increased risk of QT interval prolongation Details Bepridil Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Bepridil Disopyramide Norpace An increased risk of QT interval prolongation Details Bepridil Dofetilide Tikosyn An increased risk of QT interval prolongation Details Bepridil Dolasetron Anzemet An increased risk of QT interval prolongation Details Bepridil Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Bepridil Encorafenib Braftovi An increased risk of QT interval prolongation Details Bepridil Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Bepridil Eribulin Injection Halaven An increased risk of QT interval prolongation Details Bepridil Famotidine Calmicid An increased risk of QT interval prolongation Details Bepridil Famotidine Injection Calmicid An increased risk of QT interval prolongation Details Bepridil Felbamate Felbatol An increased risk of QT interval prolongation Details Bepridil Flecainide Tambocor® An increased risk of QT interval prolongation Details Bepridil Foscarnet Injection Foscavir An increased risk of QT interval prolongation Details Bepridil Fostemsavir Rukobia An increased risk of QT interval prolongation Details Bepridil Galantamine Razadyne An increased risk of QT interval prolongation Details Bepridil Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Bepridil Gemifloxacin Factive An increased risk of QT interval prolongation Details Bepridil Glasdegib Daurismo An increased risk of QT interval prolongation Details Bepridil Goserelin Implant Zoladex An increased risk of QT interval prolongation Details Bepridil Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Bepridil Granisetron Injection Granisol An increased risk of QT interval prolongation Details Bepridil Histrelin Implant Supprelin An increased risk of QT interval prolongation Details Bepridil Hydroxychloroquine Plaquenil An increased risk of QT interval prolongation Details Bepridil Inotuzumab Ozogamicin Injection Besponsa An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.